Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

Cancer fears calmed for metal-on-metal hips. Research highlights the pitfalls of administrative data. More research news.

You may also be interested in...

Metal-On-Metal Hips Get Failing Grade In New Registry Analysis

Devices were linked to a notably higher five-year revision rate compared to metal-on-polyethylene or ceramic-on-ceramic hips in an analysis of more than 400,000 implants. Recalled J&J/DePuy ASR devices were not included in the analysis.

HHS Will Delay ICD-10 Coding Expansion, Citing Provider Burden

The government will push back its October 2013 compliance date for switching from ICD-9 to the much-expanded ICD-10 reimbursement codes in response to providers’ arguments that near-term transition would disrupt care. The device industry supports a quicker move to ICD-10.

Ablating Blood Pressure: Ardian's RF Catheter Hits Hypertension Endpoint

Start-up firm Ardian's Symplicity ablation catheter showed success in reducing blood pressure in severe hypertension patients in its first randomized trial (Symplicity HTN-2), reported Nov. 17 at the American Heart Association annual scientific sessions in Chicago and in The Lancet.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts